Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
3862
¥ millionWording
Conditional
How definitive the wording is.This transaction
Share acquisitionDisclosing companyExcite Holdings Co.,Ltd.
TimelineThe spacing between the points is proportional to the actual number of days.2 days from 締結 to 実行.White points represent dates designated as scheduled dates in the document.
Target company
オンライン診療支援事業、メディア事業
Location Minato-ku, TokyoShare capital ¥15 millionDate of incorporation 2014年３月31日
Net Sales959百万円（2025年２月期上期実績（３～８月））
Operating profit255百万円（2025年２月期上期実績（３～８月））
Net assets1,669百万円（2024年８月31日時点）
Consideration and expenses
Acquisition price3,862百万円
Type of ConsiderationCash
Funding arrangements株式会社みずほ銀行から本株式取得を目的として3,862百万円を借り入れる。
Impact on Business Performance
本案件実行後の自己資本比率は33.4％となるが、引き続き健全な水準を維持するとしている。損益への影響額はNot disclosed。
| Item | Details |
|---|---|
| Transaction name | Share acquisition |
| Name of the Subject Company | ONE MEDICAL株式会社 |
| Business Description of the Subject Company | オンライン診療支援事業、メディア事業 |
| Location of the Subject Company | Minato-ku, Tokyo |
| Capital Stock of the Subject Company | ¥15 million |
| Date of Establishment of the Subject Company | 2014年３月31日 |
| Net Sales of the Subject Company | 959百万円（2025年２月期上期実績（３～８月）） |
| Operating Profit of the Subject Company | 255百万円（2025年２月期上期実績（３～８月）） |
| Net Assets of the Subject Company | 1,669百万円（2024年８月31日時点） |
| Acquisition price | 3,862百万円 |
| Type of Consideration | Cash |
| Funding arrangements | 株式会社みずほ銀行から本株式取得を目的として3,862百万円を借り入れる。 |
| Impact on Business Performance | 本案件実行後の自己資本比率は33.4％となるが、引き続き健全な水準を維持するとしている。損益への影響額はNot disclosed。 |
| Contract Date | 2024年10月30日（予定）（借入契約） |
| Execution Date / Effective Date | 2024年11月１日（予定） |
Items this document does not state (17)
Counterparty nameNet Income of the Subject CompanyExpenses other than the acquisition priceMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageGoodwill amountAmount of extraordinary income (loss)Date of board resolutionValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.既存事業を伸ばしながらM&Aで新たな事業の柱をつくる成長戦略に沿い、ONE MEDICALのオンライン診療支援事業を取り込んで診療領域・事業規模を拡大するため。両社の顧客基盤などを活用した送客拡大や診療科目の拡充も目指している。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.